U
BDR

UBS’s Blonder Tongue Laboratories Inc BDR Stock Holding History

UBS’s Portfolio BDR Stock Details BDR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-500
Closed – – 10957
2014
Q1 		$0 Buy
+500
New +$483 ﹤0.01% 10959
2013
Q3 		– Sell
-1,434
Closed -$2K – 10816
2013
Q2 		$2K Buy
+1,434
New +$1.49K ﹤0.01% 9858

Other funds holding BDR

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
TCM
Tufton Capital Management Hunt Valley, Maryland $596M AUM 37.37% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

UBS's BDR Position: Q2 2014 in Review

UBS sold out of Blonder Tongue Laboratories Inc (BDR) in Q2 2014, closing a stake of 500 shares.

UBS first reported a position in BDR in Q2 2013 and held it in 2 quarters. The position peaked at $2K in Q2 2013. 5 funds tracked by Wall St. Rank hold BDR as of Q2 2014.

  • UBS reported no remaining Blonder Tongue Laboratories Inc position as of Q2 2014 after selling out during the quarter.
  • UBS sold 500 Blonder Tongue Laboratories Inc shares in Q2 2014.
  • UBS first reported a position in Blonder Tongue Laboratories Inc in Q2 2013 and held it in 2 quarters.
  • UBS's Blonder Tongue Laboratories Inc position peaked at $2K in Q2 2013.
  • 5 funds tracked by Wall St. Rank held Blonder Tongue Laboratories Inc as of Q2 2014.

Based on UBS's 13F filing for Q2 2014, filed 14 Aug 2014.